Cover Image
市場調查報告書

開發藥劑中層析法樹脂的全球市場趨勢、預測 2020年:離子交換層析法—樹脂、親和性層析法樹脂、粒徑篩析層析法樹脂、多模態層析法樹脂

Chromatography Resins Market in Drug Discovery by Technique (Ion Exchange, Affinity (Protein A, G & L), Hydrophobic Interaction, Size Exclusion, Multi Modal and Others) & Geography - Global Market Trends & Forecasts to 2020

出版商 MarketsandMarkets 商品編碼 328613
出版日期 內容資訊 英文 138 Pages; 86 Tables; 62 Figures
訂單完成後即時交付
價格
Back to Top
開發藥劑中層析法樹脂的全球市場趨勢、預測 2020年:離子交換層析法—樹脂、親和性層析法樹脂、粒徑篩析層析法樹脂、多模態層析法樹脂 Chromatography Resins Market in Drug Discovery by Technique (Ion Exchange, Affinity (Protein A, G & L), Hydrophobic Interaction, Size Exclusion, Multi Modal and Others) & Geography - Global Market Trends & Forecasts to 2020
出版日期: 2015年04月17日 內容資訊: 英文 138 Pages; 86 Tables; 62 Figures
簡介

層析法在單株抗體製造、煉製的各階段中大量消費。由於全世界的重病增加,單株抗體製造領域的層析法樹脂的需求預計以高比例上升。開發藥劑中層析法樹脂的全球市場預計至2020年成長至3億5,988萬美元。

本報告提供全球開發藥劑中層析法樹脂之相關詳細分析、各技術、地區的分析與預測、競爭情形分析、主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 層析法樹脂市場上富有魅力的市場機會
  • 開發藥劑中層析法樹脂:地區區分
  • 北美親和性樹脂
  • 層析法樹脂市場魅力
  • 層析法樹脂市場:各技術
  • 層析法樹脂市場:新興國家 vs. 已開發國家
  • 最急速成長的市場:各技術
  • 生命週期分析:各地區

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態

第6章 產業趨勢

  • 簡介
  • 價值鏈分析
  • 波特的五力分析
  • 策略性基準

第7章 開發藥劑中層析法樹脂市場:各技術

  • 簡介
  • 市場規模、預測
  • 離子交換層析法—樹脂 (IEX樹脂)
  • 親和性層析法樹脂
  • 疏水交互作用層析法 (HIC)
  • 粒徑篩析層析法樹脂 (SEC樹脂)
  • 多模態層析法樹脂
  • 其他

第8章 開發藥劑中層析法樹脂市場:各地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第9章 競爭情形

  • 概要
  • 新產品銷售:最常見的成長策略
  • 北美最大的發展:2010-2014年
  • 最大的發展的記錄:2011年
  • GENERAL ELECTRIC COMPANY:最活躍的企業 2010-2014年
  • 競爭情形 & 趨勢

第10章 企業簡介

  • 簡介
  • MERCK KGAA
  • Tosoh
  • GENERAL ELECTRIC COMPANY
  • PALL CORPORATION
  • BIO-RAD LABORATORIES, INC.
  • THERMO FISHER SCIENTIFIC INC.
  • PUROLITE CORPORATION
  • SEPRAGEN CORPORATION
  • KNAUER WISSENSCHAFTLICHE GERATE GMBH
  • Kaneka
  • GENSCRIPT USA INC.

第11章 附錄

目錄
Product Code: CH 3328

The market for chromatography resins in drug discovery application is estimated at $238.07 Million in 2014 and is projected to grow at a CAGR of 7.0% between 2015 and 2020. The chromatography resins for drug discovery can be made of natural polymers, synthetic polymers or inorganic materials with ligands attached to them. This report on chromatography resins market in drug discovery covers all major regions such as Asia-Pacific, North America, Europe, and Rest of the World. The report analyzes market trends and forecasts from 2013 to 2020. Market estimations have been provided in terms of consumption volume (liters) and market revenue (USD). The global as well as regional markets have been segmented by technique such as ion exchange, affinity, hydrophobic interaction, size exclusion, multi-modal and others.

The report analyzes the market dynamics such as drivers, restraints, and opportunities, and winning imperatives. Major companies such as General Electric Company, Bio-Rad Laboratories, Thermo Fisher, Tosoh Corporation, and Pall Corporation have been profiled in this report. The report also provide the analysis of competitive landscape based on the recent developments in the market.

For this report, various secondary sources such as chemical magazines, encyclopedia, directories, technical handbooks, company annual reports, industry association publications, articles, trade websites, and databases have been referred to identify and collect information useful for this extensive commercial study of global chromatography resins market in drug discovery. The primary sources - experts from related industries and suppliers - have been interviewed to obtain and verify critical information as well as to assess the future prospects and market estimations.

The chromatography resins market in drug discovery is highly consolidatesd with presence of a few global manufacturers who capture a large share of the market. These manufacturers are focused on providing advanced products to their customers and in the recent past have launched a number of new products.

Chromatography resins for drug discovery can be classified into six categories based on the technique they are used in. Affinity chromatography is the largest segment, in terms of value. It accounts for around half the total market size, primarily due to its high cost. The Proetin A chromatography is the largest sub-type. The increase in critical diseases has led to high demand for therapeutic monoclonal antibodies, driving along with it the demand for Protein A affinity chromatography.

Table of Contents

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
      • 1.3.1.1. By technique
      • 1.3.1.2. By region
    • 1.3.2. YEARS CONSIDERED
  • 1.4. CURRENCY & PRICING
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY INSIGHTS
    • 2.3.2. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE OPPORTUNITIES IN THE CHROMATOGRAPHY RESINS MARKET
  • 4.2. CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY: REGIONAL SEGMENTS
  • 4.3. AFFINITY RESINS MARKET IN NORTH AMERICA
  • 4.4. CHROMATOGRAPHY RESINS MARKET ATTRACTIVENESS
  • 4.5. CHROMATOGRAPHY RESINS MARKET, BY TECHNIQUE (2014)
  • 4.6. CHROMATOGRAPHY RESINS MARKET: DEVELOPING VS. DEVELOPED NATIONS
  • 4.7. FASTEST-GROWING MARKETS, BY TECHNIQUE (2014)
  • 4.8. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing demand for therapeutic antibodies
      • 5.3.1.2. Growing biopharmaceutical R&D activities
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High-cost of affinity resins
      • 5.3.2.2. Lack of adequate skilled professionals
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. High growth of biopharmaceutical R&D activity in Asia-Pacific
      • 5.3.3.2. Increasing demand for disposable pre-packed columns

6. INDUSTRY TRENDS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. PORTER'S FIVE FORCES ANALYSIS
    • 6.3.1. THREAT OF SUBSTITUTES
    • 6.3.2. BARGAINING POWER OF SUPPLIERS
    • 6.3.3. BARGAINING POWER OF BUYERS
    • 6.3.4. THREAT OF NEW ENTRANTS
    • 6.3.5. INTENSITY OF RIVALRY
  • 6.4. STRATEGIC BENCHMARKING
    • 6.4.1. NEW PRODUCT LAUNCHES
    • 6.4.2. RESEARCH & DEVELOPMENT

7. CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY, BY TECHNIQUE

  • 7.1. INTRODUCTION
  • 7.2. MARKET SIZE & PROJECTION
  • 7.3. ION EXCHANGE CHROMATOGRAPHY (IEX) RESINS
  • 7.4. AFFINITY CHROMATOGRAPHY RESINS
    • 7.4.1. PROTEIN A AFFINITY RESINS
    • 7.4.2. PROTEIN G/L AFFINITY RESINS
  • 7.5. HYDROPHOBIC INTERACTION CHROMATOGRAPHY (HIC)
  • 7.6. SIZE EXCLUSION CHROMATOGRAPHY (SEC) RESINS
  • 7.7. MULTI-MODAL CHROMATOGRAPHY RESINS
  • 7.8. OTHERS

8. CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY, REGIONAL ANALYSIS

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. GROWTH IN NORTH AMERICA IS DRIVEN BY THE DEMAND IN U.S.
    • 8.2.2. U.S.
    • 8.2.3. CANADA
    • 8.2.4. MEXICO
  • 8.3. EUROPE
    • 8.3.1. U.K.
    • 8.3.2. GERMANY
    • 8.3.3. FRANCE
    • 8.3.4. SPAIN
    • 8.3.5. AUSTRIA & SWITZERLAND
    • 8.3.6. SCANDINAVIA
  • 8.4. ASIA-PACIFIC
    • 8.4.1. CHINA
    • 8.4.2. JAPAN
    • 8.4.3. SOUTH KOREA
    • 8.4.4. INDIA
  • 8.5. ROW
    • 8.5.1. BRAZIL
    • 8.5.2. MIDDLE EAST
    • 8.5.3. AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. NEW PRODUCT LAUNCHES: THE MOST POPULAR GROWTH STRATEGY
  • 9.3. MAXIMUM DEVELOPMENTS IN NORTH AMERICA, 2010-2014
  • 9.4. MAXIMUM DEVELOPMENTS RECORDED IN 2011
  • 9.5. GENERAL ELECTRIC COMPANY: THE MOST ACTIVE PLAYER BETWEEN 2010 & 2014
  • 9.6. COMPETITIVE SITUATION & TRENDS
    • 9.6.1. NEW PRODUCT LAUNCHES
    • 9.6.2. RESEARCH & DEVELOPMENT
    • 9.6.3. MERGERS & ACQUISITIONS
    • 9.6.4. CONTRACTS & AGREEMENTS
    • 9.6.5. EXPANSIONS

10. COMPANY PROFILES (Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*

  • 10.1. INTRODUCTION
  • 10.2. MERCK KGAA
  • 10.3. TOSOH CORPORATION
  • 10.4. GENERAL ELECTRIC COMPANY
  • 10.5. PALL CORPORATION
  • 10.6. BIO-RAD LABORATORIES, INC.
  • 10.7. THERMO FISHER SCIENTIFIC INC.
  • 10.8. PUROLITE CORPORATION
  • 10.9. SEPRAGEN CORPORATION
  • 10.10. KNAUER WISSENSCHAFTLICHE GERÄTE GMBH
  • 10.11. KANEKA CORPORATION
  • 10.12. GENSCRIPT USA INC.

*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. INSIGTHS FROM INDUSTRY EXPERTS
  • 11.2. RECENT DEVELOPMENTS
  • 11.3. DISCUSSION GUIDE
  • 11.4. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 11.5. AVAILABLE CUSTOMIZATIONS
  • 11.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: BIOSIMILARS IN RESEARCH & DEVELOPMENT, 2014
  • TABLE 2: IMPACT ANALYSIS OF DRIVERS
  • TABLE 3: IMPACT ANALYSIS OF RESTRAINTS
  • TABLE 4: IMPACT ANALYSIS OF OPPORTUNITIES
  • TABLE 5: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 6: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 7: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 8: IEX CHROMATOGRAPHY RESIN MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS)
  • TABLE 9: ION EXCHANGE CHROMATOGRAPHY RESIN MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 10: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS)
  • TABLE 11: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 12: PROTEIN A RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 13: PROTEIN G/L RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 14: PROTEIN A, G & L: BINDING CAPACITIES FOR DIFFERENT IMMUNOGLOBULIN SPECIES
  • TABLE 15: HIC RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS)
  • TABLE 16: HIC RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 17: SEC RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS)
  • TABLE 18: SEC RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 19: MULTI-MODAL RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS)
  • TABLE 20: MULTI-MODAL RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 21: OTHER RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS)
  • TABLE 22: OTHER RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 23: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 (LITERS)
  • TABLE 24: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 25: NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 (LITERS)
  • TABLE 26: NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 27: U.S.: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 28: U.S.: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 29: U.S.: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 30: CANADA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 31: CANADA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 32: CANADA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 33: MEXICO: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 34: MEXICO: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 35: MEXICO: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 36: EUROPE: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 (LITERS)
  • TABLE 37: EUROPE: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 38: U.K.: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 39: U.K.: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 40: U.K.: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 41: GERMANY: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 42: GERMANY: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 43: GERMANY: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 44: FRANCE: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 45: FRANCE: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 46: FRANCE: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 47: SPAIN: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 48: SPAIN: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 49: SPAIN: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 50: AUSTRIA & SWITZERLAND: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 51: AUSTRIA & SWITZERLAND: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 52: AUSTRIA & SWITZERLAND: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 53: SCANDINAVIA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 54: SCANDINAVIA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 55: SCANDINAVIA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 56: ASIA-PACIFIC: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 (LITERS)
  • TABLE 57: ASIA-PACIFIC: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 58: CHINA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 59: CHINA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 60: CHINA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 61: JAPAN: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 62: JAPAN: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 63: JAPAN: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 64: SOUTH KOREA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 65: SOUTH KOREA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 66: SOUTH KOREA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 67: INDIA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 68: INDIA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 69: INDIA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 70: ROW: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 (LITERS)
  • TABLE 71: ROW: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 72: BRAZIL: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 73: BRAZIL: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 74: BRAZIL: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 75: MIDDLE EAST: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 76: MIDDLE EAST: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 77: MIDDLE EAST: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 78: AFRICA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 (LITERS)
  • TABLE 79: AFRICA: CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TECHNIQUE, 2013-2020 ($MILLION)
  • TABLE 80: AFRICA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE IN DRUG DISCOVERY, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 81: NEW PRODUCT LAUNCH, 2010-2014
  • TABLE 82: RESEARCH & DEVELOPMENT, 2010-2014
  • TABLE 83: MERGERS & ACQUISITIONS, 2010-2014
  • TABLE 84: CONTRACTS & AGREEMENTS, 2010-2014
  • TABLE 85: EXPANSIONS, 2010-2014
  • TABLE 86: DEVELOPMENTS, 2010-2014

LIST OF FIGURES

  • FIGURE 1: CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY, RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAK DOWN OF PRIMARY INTERVIEWS, BY DESIGNATION & REGION
  • FIGURE 5: CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY: DATA TRIANGULATION
  • FIGURE 6: DATA FROM SECONDARY SOURCES
  • FIGURE 7: DATA FROM PRIMARY SOURCES
  • FIGURE 8: PROTEIN A TO DOMINATE THE MARKET
  • FIGURE 9: AFFINITY CHROMATOGRAPHY MARKET TO REGISTER THE FASTEST GROWTH IN ASIA-PACIFIC
  • FIGURE 10: CHINA IS THE LARGEST CONSUMER OF PROTEIN A AFFINITY CHROMATOGRAPHY
  • FIGURE 11: CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY TO REGISTER MODERATE GROWTH
  • FIGURE 12: ASIA-PACIFIC TO GROW AT HIGHEST RATE BETWEEN 2015 & 2020
  • FIGURE 13: U.S. CAPTURES THE LION'S SHARE IN THE NORTH AMERICA AFFINITY RESINS MARKET IN 2014
  • FIGURE 14: CHINA, MEXICO & INDIA WILL BE THE FASTEST-GROWING MARKETS DURING THE PROJECTED PERIOD
  • FIGURE 15: AFFINITY RESINS TO BE THE MOST ATTRACTIVE MARKET
  • FIGURE 16: CHINA TO EMERGE AS A LUCRATIVE MARKET
  • FIGURE 17: CHROMATOGRAPHY RESINS IN DRUG DISCOVERY HAS HIGH GROWTH POTENTIAL IN THE EMERGING ECONOMIES
  • FIGURE 18: HIGH GROWTH POTENTIAL IN ASIA-PACIFIC FOR THE CHROMATOGRAPHY RESINS IN DRUG DISCOVERY
  • FIGURE 19: BY TECHNIQUE
  • FIGURE 20: BY REGION
  • FIGURE 21: OVERVIEW OF THE MARKET FORCES GOVERNING CHROMATOGRAPHY RESINS MARKET
  • FIGURE 22: ANNUAL APPROVALS OF MAB & ITS RELATED PRODUCTS IN U.S. & EUROPE, 2003- 2014
  • FIGURE 23: SPENDING ON BIOPHARMACEUTICAL RESEARCH, 2005-2020 ($BILLION)
  • FIGURE 24: VALUE CHAIN ANALYSIS FOR CHROMATOGRAPHY RESINS IN DRUG DISCOVERY
  • FIGURE 25: PORTER'S FIVE FORCES ANALYSIS: ENTRY OF NEW PLAYERS WILL IMPACT THE MARKET
  • FIGURE 26: STRATEGIC BENCHMARKING: KEY PLAYERS LAUNCHED A NUMBER OF NEW PRODUCTS
  • FIGURE 27: STRATEGIC BENCHMARKING: COMPANIES FOCUSED ON INNOVATION
  • FIGURE 28: AFFINITY RESINS TO REGISTER THE HIGHEST CAGR FOR THE PROJECTED PERIOD
  • FIGURE 29: NORTH AMERICA IS THE LARGEST MARKET FOR IEX RESINS
  • FIGURE 30: INCREASING DEMAND FOR ANTIBODY PURIFICATION IN DRUG DISCOVERY TO DRIVE THE AFFINITY RESINS MARKET
  • FIGURE 31: HIC RESINS TO WITNESS DECENT GROWTH DURING THE FORECAST PERIOD
  • FIGURE 32: NORTH AMERICA IS THE LARGEST MARKET FOR SEC RESINS IN DRUG DISCOVERY
  • FIGURE 33: NORTH AMERICA TO DOMINATE THE MARKET
  • FIGURE 34: EARLY-STAGE-PURIFICATION REQUIREMENTS TO DRIVE DEMAND FOR OTHER CHROMATOGRAPHY RESINS
  • FIGURE 35: REGIONAL SNAPSHOT (2015-2020)-RAPID GROWTH MARKETS ARE EMERGING AS NEW STRATEGIC LOCATIONS
  • FIGURE 36: PROTEIN A AFFINITY RESINS IN CHINA TO WITNESS HIGH GROWTH
  • FIGURE 37: NORTH AMERICA MARKET SNAPSHOT: U.S. TO CONTINUE TO DOMINATE THE MARKET
  • FIGURE 38: EUROPE MARKET SNAPSHOT: GERMANY, AUSTRIA & SWITZERLAND EXPECTED TO BE LUCRATIVE MARKETS FOR PROTEIN A RESINS
  • FIGURE 39: ASIA-PACIFIC MARKET SNAPSHOT: CHINA IS THE MOST LUCRATIVE MARKET
  • FIGURE 40: BRAZIL DOMINATES THE ROW CHROMATOGRAPHY RESINS MARKET
  • FIGURE 41: KEY GROWTH STRATEGIES IN CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY, 2010-2014
  • FIGURE 42: COMPANIES PRIMARILY ADOPTED ORGANIC GROWTH STRATEGIES
  • FIGURE 43: NEW PRODUCT LAUNCHES MADE NORTH AMERICA THE MOST ACTIVE REGION
  • FIGURE 44: CHROMATOGRAPHY RESINS MARKET IN DRUG DISCOVERY DEVELOPMENTAL SHARE, 2010-2014
  • FIGURE 45: GROWTH STRATEGIES SHARE, BY COMPANY, 2010-2014
  • FIGURE 46: REGIONAL REVENUE MIX OF TOP 5 MARKET PLAYERS
  • FIGURE 47: MERCK KGAA: BUSINESS OVERVIEW
  • FIGURE 48: MERCK KGAA: SWOT ANALYSIS
  • FIGURE 49: TOSOH CORPORATION: BUSINESS OVERVIEW
  • FIGURE 50: TOSOH CORPORATION: SWOT ANALYSIS
  • FIGURE 51: GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
  • FIGURE 52: GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
  • FIGURE 53: PALL CORPORATION: BUSINESS OVERVIEW
  • FIGURE 54: PALL CORPORATION: SWOT ANALYSIS
  • FIGURE 55: BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
  • FIGURE 56: BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
  • FIGURE 57: THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
  • FIGURE 58: PUROLITE CORPORATION: BUSINESS OVERVIEW
  • FIGURE 59: SEPRAGEN CORPORATION: BUSINESS OVERVIEW
  • FIGURE 60: KNAUER WISSENSCHAFTLICHE GERÄTE GMBH: BUSINESS OVERVIEW
  • FIGURE 61: KANEKA CORPORATION: BUSINESS OVERVIEW
  • FIGURE 62: GENSCRIPT USA INC.: BUSINESS OVERVIEW
Back to Top